Showing results (61-70 of 93) with videos related to
Sort By:
Pageof 10
The Annals of Pharmacotherapy|February 24, 2006
Are shorter courses of filgrastim prophylaxis associated with increased risk of hospitalization?Derek Weycker, James Hackett, John S Edelsberg, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 9, 2007
Levels of zinc, selenium, calcium, and iron in benign breast tissue and risk of subsequent breast cancerYan Cui, Stefan Vogt, Neal Olson, et al.Journal of Medical Economics|July 14, 2025
Cost-effectiveness analysis of pembrolizumab as an adjuvant treatment of early-stage non-small cell lung cancer following complete resection and platinum-based chemotherapy in CanadaSylvi Nguyen, Elizabeth Wehler, Chloe Langevin, et al.Plos One|February 13, 2018
MicroRNA expression in benign breast tissue and risk of subsequent invasive breast cancerThomas Rohan, Kenny Ye, Yihong Wang, et al.BMC Health Services Research|April 29, 2014
Risk and consequences of chemotherapy-induced neutropenic complications in patients receiving daily filgrastim: the importance of duration of prophylaxisDerek Weycker, Rich Barron, John Edelsberg, et al.Cancer Causes & Control : CCC|June 8, 2013
Efficacy of screening in preventing cervical cancer among older womenAruna Kamineni, Sheila Weinmann, Kirkwood K Shy, et al.Breast Cancer Research and Treatment|April 13, 2018
Correction to: Association between lifestyle, menstrual/reproductive history, and histological factors and risk of breast cancer in women biopsied for benign breast diseaseRhonda Arthur, Yihong Wang, Kenny Ye, et al.Breast Cancer Research and Treatment|June 24, 2017
Association between lifestyle, menstrual/reproductive history, and histological factors and risk of breast cancer in women biopsied for benign breast diseaseRhonda Arthur, Yihong Wang, Kenny Ye, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 10, 2010
Incidence, duration, and reappearance of type-specific cervical human papillomavirus infections in young womenRalph P Insinga, Gonzalo Perez, Cosette M Wheeler, et al.Gynecologic Oncology|May 26, 2009
Age-appropriate use of human papillomavirus vaccines in the U.SPhilip E Castle, Barbara Fetterman, Israh Akhtar, et al.Pageof 10